Faricimab
Product Specifications
CAS Number
1607793-29-2
Target
RAAS, VEGFR
Related Pathways
Endocrinology/Hormones, Angiogenesis, Tyrosine Kinase/Adaptors
Purity
>95%
Bioactivity
Faricimab, a bispecific antibody targeting Angiopoietin-2 (Ang-2) and VEGF-A. Faricimab prevents retinal ischemia/reperfusion (I/R) injury and vascular leakage, cell death, and inflammation in sCNV mouse models, showing superior visual acuity improvement over ranibizumab for retinal diseases including w-AMD, DME, and RVO.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1239459-01 0.02 mg (E-Coli)
Recombinant Laribacter hongkongensis Hydroxyethylthiazole kinase (thiM)
Sign In for Pricing
View Details MBS1239459-02 0.02 mg (Yeast)
Recombinant Laribacter hongkongensis Hydroxyethylthiazole kinase (thiM)
Sign In for Pricing
View Details MBS1239459-03 0.1 mg (E-Coli)
Recombinant Laribacter hongkongensis Hydroxyethylthiazole kinase (thiM)
Sign In for Pricing
View Details MBS1239459-04 0.1 mg (Yeast)
Recombinant Laribacter hongkongensis Hydroxyethylthiazole kinase (thiM)
Sign In for Pricing
View Details MBS1239459-05 0.02 mg (Baculovirus)
Recombinant Laribacter hongkongensis Hydroxyethylthiazole kinase (thiM)
Sign In for Pricing
View Details MBS1239459-06 0.02 mg (Mammalian-Cell)
Recombinant Laribacter hongkongensis Hydroxyethylthiazole kinase (thiM)
Sign In for Pricing
View Details